1. M.B. Vallotton, The renin-angiotensin system, TIPS 8: 69 (1987).
2. S.A.M.A. Al-Merani, D.P. Brooks, B.J. Chapman and K.A. Munday, The half-lives of angiotensin II, angiotensin II-amide, angiotensin III, Sar1, Ala -angiotensin II and renin in the circulatory system of the rat, J. Physiol. 278: 471 (1978).
3. M.I. Phillips, J. Weyhenmeyer, D. Felix, D. Ganten and W.E. Hoffman, Evidence for an endogenous brain renin-angiotensin system, Federation Proc. 38: 2260 (1979).
4. M.A. Ondetti, B. Rubin, D.W. Cushman, Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents, Science 196: 441 (1977).
5. C.S. McCaa, H.G. Langford, W.C. Cushman and R.E. McCaa, Response of arterial blood pressure, plasma renin activity and plasma aldosterone concentration to long-term administration of Captopril in patients with severe, treatment-resistant malignant hypertension, Clinical Science 57: 371s (1979).